Switch to:

Denali Therapeutics Asset Impairment Charge

: $0.0 Mil (TTM As of Jun. 2019)
View and export this data going back to 2017. Start your Free Trial

Denali Therapeutics's Asset Impairment Charge for the three months ended in Jun. 2019 was $0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2019 was $0.0 Mil.


Denali Therapeutics Asset Impairment Charge Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Asset Impairment Charge 0.00 0.00 0.00 0.00

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Asset Impairment Charge Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Denali Therapeutics Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2019 was 0 (Sep. 2018 ) + 0 (Dec. 2018 ) + 0 (Mar. 2019 ) + 0 (Jun. 2019 ) = $0.0 Mil.


Denali Therapeutics Asset Impairment Charge Related Terms


Denali Therapeutics Asset Impairment Charge Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)